Search Results - "Smekal, Anna-Karin" :: K.UTB vyhledávací portál

Loading…

Low attainment to PK/PD-targets for β-lactams in a multi-center study on the first 72 h of treatment in ICU patients

by Smekal, Anna-Karin, Furebring, Mia, Eliasson, Erik, Lipcsey, Miklos
Published in Scientific reports (19.12.2022)

Get full text

Journal Article

Loading…

Population pharmacokinetics of cefotaxime in intensive care patients

by Swartling, Maria, Smekal, Anna-Karin, Furebring, Mia, Lipcsey, Miklos, Jönsson, Siv, Nielsen, Elisabet I.
Published in European journal of clinical pharmacology (01.02.2022)

Get full text

Journal Article

Loading…

Swedish multicentre study of target attainments with β-lactams in the ICU: which MIC parameter should be used?

by Smekal, Anna-Karin, Furebring, Mia, Lipcsey, Miklos, Giske, Christian G
Published in Journal of antimicrobial chemotherapy (01.12.2023)

Get full text

Journal Article

Loading…

Performance of the EUCAST disc diffusion method and two MIC methods in detection of Enterobacteriaceae with reduced susceptibility to meropenem: the NordicAST CPE study

by Haldorsen, Bjørg, Giske, Christian G, Hansen, Dennis S, Helgason, Kristjan Orri, Kahlmeter, Gunnar, Löhr, Iren H, Matuschek, Erika, Österblad, Monica, Rantakokko-Jalava, Kaisu, Wang, Mikala, Småbrekke, Lars, Samuelsen, Ørjan, Sundsfjord, Arnfinn
Published in Journal of antimicrobial chemotherapy (01.10.2018)

Get full text

Journal Article

Low attainment to PK/PD-targets for β-lactams in a multi-center study on the first 72 h of treatment in ICU patients

Population pharmacokinetics of cefotaxime in intensive care patients

Swedish multicentre study of target attainments with β-lactams in the ICU: which MIC parameter should be used?

Performance of the EUCAST disc diffusion method and two MIC methods in detection of Enterobacteriaceae with reduced susceptibility to meropenem: the NordicAST CPE study

Refine Results

Format

Subject Area

Topic

Language

Year of Publication

Database